<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
FORM 8-K
-----------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 13, 2000
---------------------------
VION PHARMACEUTICALS, INC.
----------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-26534 13-3671221
------------------------------ --------------- --------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
4 Science Park, New Haven, CT 06511
---------------------------------------- -------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (203) 498-4210
-------------------
Not Applicable
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
ITEM 5. OTHER EVENTS
In a press release dated November 13, 2000, Vion Pharmaceutical Inc. (the
"Company") announced the third quarter and nine months financial results for the
period ended September 30, 2000.
A copy of the press release is attached as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) EXHIBITS.
Exhibit 99.1 Press release dated November 13, 2000 announcing the
third quarter and nine months financial results for the period
ended September 30, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VION PHARMACEUTICALS, INC.
Date: November 13, 2000 By: /s/ Alan Kessman
------------------
Name: Alan Kessman
Title: President and Chief Executive Officer
<PAGE>
EXHIBIT INDEX
99.1 Press release dated November 13, 2000 announcing the third
quarter and nine months financial results for the period
ended September 30, 2000.
STATEMENT OF DIFFERENCES
The registered trademark symbol shall be expressed as...........'r'
